Demoxepam
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one-4-oxide | |
Clinical data | |
Legal status | ? |
Pharmacokinetic data | |
Half-life | 35 to 40 h |
Identifiers | |
CAS number | 963-39-3 |
ATC code | ? |
PubChem | CID 13756 |
ChemSpider | 10441314 |
UNII | 8X1XP5M0SB |
KEGG | D02600 |
Chemical data | |
Formula | C15H11ClN2O2 |
Mol. mass | 286.713 |
SMILES
| |
| |
(what is this?) (verify) | |
Demoxepam[1] is a drug which is a benzodiazepine derivative. It is a metabolite of chlordiazepoxide and has anticonvulsant properties[2][3] and presumably other characteristic benzodiazepine properties.
See also
References
- ↑ US Patent 3136815
- ↑ "nortetrazepam". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ↑ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities (eur-lex.europa.eu). 23 October 2001. Retrieved 7 December 2009.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.